ClearPoint Neuro (CLPT) Return on Capital Employed Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,600.00 |
| Dec 31, 2025 | -772.00 |
| Sep 30, 2025 | -1,379.00 |
| Jun 30, 2025 | -3,221.00 |
| Mar 31, 2025 | -4,387.00 |
| Dec 31, 2024 | -1,521.00 |
| Sep 30, 2024 | -252.00 |
| Jun 30, 2024 | 1,092.00 |
| Mar 31, 2024 | 2,418.00 |
| Dec 31, 2023 | 1,934.00 |
| Sep 30, 2023 | 1,836.00 |
| Jun 30, 2023 | 6,402.00 |
| Mar 31, 2023 | 5,654.00 |
| Sep 30, 2021 | 15,815.00 |
| Jun 30, 2021 | 21,748.00 |
| Mar 31, 2021 | 14,650.00 |
| Sep 30, 2020 | -153,389.00 |
| Jun 30, 2020 | -626,526.00 |
| Mar 31, 2020 | 12,814.00 |
| Dec 31, 2019 | 5,380.00 |
| Sep 30, 2019 | 27,802.00 |
| Jun 30, 2019 | 2,586.00 |
| Mar 31, 2019 | 1,415.00 |
| Dec 31, 2018 | -61,826.00 |
| Sep 30, 2018 | 7,567.00 |
| Jun 30, 2018 | -4,022.00 |
| Mar 31, 2018 | 1,767.00 |